featured
Scoring System for Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients With MRI-Detected PI-RADS/Likert ≥3 Lesions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging-detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score
Eur Urol 2022 Aug 10;[EPub Ahead of Print], M Peters, D Eldred-Evans, P Kurver, UG Falagario, MJ Connor, TT Shah, JJC Verhoeff, P Taimen, HJ Aronen, J Knaapila, I Montoya Perez, O Ettala, A Stabile, G Gandaglia, N Fossati, A Martini, V Cucchiara, A Briganti, A Lantz, W Picker, ES Haug, T Nordström, MB Tanaka, D Reddy, E Bass, PSN van Rossum, K Wong, H Tam, M Winkler, S Gordon, H Qazi, PJ Boström, I Jambor, HU AhmedFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.